Traws Pharma, Inc. Restructuring Reserve, Current
Traws Pharma, Inc. (TRAW) had Restructuring Reserve, Current of $127.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes
us-gaap:RestructuringReserveCurrent · last filed 2024-11-14
- 2024-09-30: Restructuring Reserve, Current $127.00K.
- 2024-06-30: Restructuring Reserve, Current $504.00K.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2024-09-30 | $127.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $504.00K 10-Q · filed 2024-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |